secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2025-01-15T23:59:59+00:00
Accession:  0001708599-25-000005
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina Therapeutics appoints Karen J. Wilson to board; Steven Mintz departs
---------------------------------------------------------------------------

- Karen J. Wilson appointed effective Jan 14, 2025; over 30 years life sciences finance experience, CPA.
- Wilson will serve as Compensation Committee Chair and on the Audit Committee.
- Steven Mintz departs board; no disagreement; Remy Gross replaces as Audit Committee chair.
- Wilson also serves on boards of Connect Biopharma, Elicio Therapeutics, and LAVA Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/0001708599-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859925000005/ser-20250114.htm
  HTML page:      https://secwatch.observer/filing/0001708599-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer